Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:


| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $263 | In Stock | In Stock | |
| 5 mg | $645 | In Stock | In Stock | |
| 10 mg | $943 | In Stock | In Stock | |
| 25 mg | $1,380 | In Stock | In Stock | |
| 50 mg | $1,880 | In Stock | In Stock | |
| 100 mg | $2,530 | In Stock | In Stock |
| Description | C004019 belongs to PROTACs and is a tau protein-targeted degrader (via recruitment of VHL E3 ligase) with blood-brain barrier permeability and selective tau degradation capability. This compound significantly reduces tau levels and improves cognitive function, and is used in research on Alzheimer's disease and related tauopathies. |
| Targets & IC50 | HEK293-hTau cells:0.00785 μM |
| In vitro | Methods: HEK293 cells stably expressing full-length human tau protein (HEK293-hTau) and SH-SY5Y cells were treated with C004019 for 24 h, and cell viability and tau protein expression levels were detected, respectively. Results: Within the concentration range of 0.01–100 μM, C004019 had no significant effect on HEK293-hTau cell viability; at concentrations of 0.01–20 μM, C004019 inhibited total tau and phosphorylated tau protein expression.[1] |
| In vivo | Methods: To evaluate the clearance of brain tau protein and effects on cognitive function by C004019, different administration Methods were employed in wild-type, 3xTg-AD, and hTau mouse models: single intracerebroventricular injection of C004019 (5 μL, 200 μM); single subcutaneous injection (3-15 mg/kg); and long-term subcutaneous injection (3 mg/kg, once every 6 days for a total of 5 times), with detection of brain tau protein levels, cognitive function, and synaptic function changes. Results: Intracerebroventricular administration of C004019 reduced brain tau protein levels in wild-type and 3xTg-AD mice; single subcutaneous injection effectively cleared brain tau protein in wild-type mice; long-term subcutaneous injection promoted brain tau protein clearance in hTau and 3xTg-AD mice and improved their cognitive and synaptic function.[1] |
| Molecular Weight | 1035.29 |
| Formula | C49H70N12O9S2 |
| Cas No. | 2417159-57-8 |
| Smiles | N(CC(NCCOCCOCCOCC(N[C@H](C(=O)N1[C@@H](C(NCC2=CC=C(C=C2)C3=C(C)N=CS3)=O)C[C@H](O)C1)C(C)(C)C)=O)=O)(C)C4=NC(=NC(NCCC5=CC=CS5)=N4)N6CCN(C(C)=O)CCC6 |
| Relative Density. | 1.300 g/cm3 (Predicted) |
| Storage | Keep away from direct sunlight Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 255 mg/mL (246.31 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.